Retail pharmacy or the big reshuffle of "people" in hand to cooperate with Guangyao

The new medical reform policy has benefited the pharmaceutical industry in many ways, but pharmacies are struggling. It is reported that at present, hundreds of thousands of pharmacies across the country are entering an unprecedented low point of development.

Xie Zilong, Chairman of People's Pharmacy Chain Co., Ltd., saw the first sentence of this reporter's report that “the days of drugstores are very bitter”! According to him, the various policies and policies of the new medical reform alone did not include the development of the retail pharmacy industry.

Retail pharmacies will be reshuffled next year

It is reported that after the introduction of the new medical reform, pharmacies cannot profit from the "separation of medicines" because of the reason that prescriptions do not flow out.

In addition, the sale of essential drugs with “zero margin” (ie, basic drugs sold in primary medical institutions will be leveled out, no more sales will be given to patients), and a high proportion of basic drug reimbursement will all lead to long-term survival based on price advantage. Pharmacies are becoming less and less adversaries in the face of basic medical institutions.

“The next year will be even harder, because the basic drug system in many places will be more standardized and strictly enforced, and the proportion of retail pharmacies as a whole relative to hospitals will shrink further. At this time next year, the retail pharmacy reshuffle will really come.” Xie Zilong Say.

Industry "test water": production and marketing cooperation for OEM

It is the above difficulties that “really” retail pharmacies are actively looking for new models for development. If the pharmacy industry is guided by the trend of “parity” in the first decade, then “seamless integration” with upstream drug companies will become the next decade. Pharmacies increase the mainstream of gross margins.

The People’s Pharmacy Chain Co., Ltd. and Guangpharm Group are exploring the possibility of third-party drug companies co-branding. Li Chuyuan, general manager of Guangyao Pharmaceutical Group, said that this is also a further extension of the traditional pharmaceutical industry "front shop and factory."

"Guangzhou Pharmaceuticals can take part of the approval documents to sell the products to the ordinary people. At the same time, it can also explore the modes of commissioned production and chained underwriting of Guangyao Pharmaceutical and direct sales of products."

Li Chuyuan also stated that cooperation with ordinary people's pharmacies is also an important step for Guangpharm Group's nationwide expansion. "600 people" stores spread all over the country, and Guangyao still needs deep ploughing in markets outside South China. Guangphong is relying on people's channels. To achieve the nationwide development of brands and products.

Xie Zilong said that although the pharmacy drug company's production and marketing cooperation has been for many years, it is basically a simple trading relationship, and the cooperation with Guangpah Pharmaceutical will create a new model of production and marketing cooperation.

"People" will merge 3 chains in the next March

Xie Zilong, chairman of the People's Pharmacy Chain Co., Ltd., disclosed to the reporter at the end of last week that within three months, the company will continue to acquire three regional chain pharmacy companies with a sales scale of 100 million to 200 million yuan. It is estimated that in 2011, the sales of ordinary people's pharmacies will reach 3.5 billion yuan.

Xie Zilong said that within 3 years, the people will have a provincial store with annual sales of 1 billion yuan and five stores with annual sales of 500 million yuan. In addition, Xie Zilong disclosed that the company is already doing pre-listing counseling and plans to list on the A-share market. (Reporter Huang Pei)